Gladstone NOW: The Campaign Join Us on the Journey ✕
1 - 15 of 371 Results Clear All
For Cancer Immunotherapy Month, Karin Pelka answers questions about how immunotherapy can treat patients with solid tumors and the challenges that scientists are working to overcome.
Gladstone Experts Cancer Genomic Immunology Data Science and Biotechnology Pelka Lab
Discover how Gladstone fosters an environment in which people are having fun, working hard, and driven to save human lives.
Gladstone Experts Graduate Students and Postdocs Institutional News
The Voice of San Francisco—Gladstone President Deepak Srivastava reflects on how uncertainties about federal research funding are jeopardizing scientists’ efforts to find new disease cures.
Gladstone Experts Srivastava Lab AI
Bruce Conklin and his team at Gladstone are tackling Charcot-Marie-Tooth (CMT) disease, the most common inherited neurological disorders—for which there is currently no cure.
Gladstone Experts Conklin Lab CRISPR/Gene Editing
AARP—Lennart Mucke, director of the Gladstone Institute of Neurological Disease, does not think that viruses cause Alzheimer's disease, but suggests that they may act as environmental triggers that interact with genetic factors to contribute to disease.
Gladstone Experts Alzheimer’s Disease Neurological Disease Mucke Lab
For National DNA Day, discover how Gladstone scientists are utilizing the power of DNA to deepen our understanding of disease.
Gladstone Experts Genomic Immunology Data Science and Biotechnology Marson Lab Pollard Lab Ramani Lab Shipman Lab Tcheandjieu Lab Big Data CRISPR/Gene Editing
The San Francisco Standard—The San Francisco Standard published a list of 100 of the most influential, powerful, and culturally relevant people in San Francisco. Gladstone President Deepak Srivastava was named to the list as one of “The Solvers”, who, in a city full of old challenges, are finding new solutions. Srivastava was recognized due to his leadership of leading scientists searching for breakthroughs in immunology, stem cells, neurodegenerative diseases, HIV, and cancer.
Gladstone Experts Srivastava Lab
Nature—In the 1980s, scientists began studying a family that suffered a genetic form of early-onset Alzheimer’s disease. Three decades later, they identified one member of that family who showed remarkable protection against the cognitive decline of Alzheimer’s due to a rare mutation in the ApoE gene. Now, Gladstone Senior Investigator Yadong Huang and others are working to develop therapies that mimic that protective mutation, hoping to treat or even prevent Alzheimer’s disease.
Gladstone Experts Alzheimer’s Disease Huang Lab
Nature—Bacteria are under constant attack from viruses called bacteriophages, and have evolved complex methods to fight off those invaders. Gladstone Investigator Seth Shipman describes how his group is capitalizing on one of those bacterial defense systems—retrons—to create new molecular biology tools.
Gladstone Experts Data Science and Biotechnology Shipman Lab CRISPR/Gene Editing
The Naked Scientists—Melanie Ott, director of the Gladstone Institute of Virology, explains that the measles virus does not just cause a cough and a skin rash; it can spread to the whole body, including the brain, erase our immune memories, and in some cases be fatal.
Gladstone Experts Virology Ott Lab
Melanie Ott talks about the ongoing measles outbreak, explains how vaccination can lower the risk of Alzheimer’s, and shares other positive “side effects” of vaccines.
Gladstone Experts Virology
KUSI News—Melanie Ott, director of the Gladstone Institute of Virology, explains that measles can have severe and lasting consequences in some people, especially children, and that the measles vaccine provides life-long protection in the vast majority of vaccinated people.
Gladstone Experts Virology Ott Lab
The Washington Post—As it explores whether reprogramming our genes can make us young again, this article highlights the Noble Prize winning discovery by Gladstone Investigator Shinya Yamanaka. (Subscription required.)
Gladstone Experts Yamanaka Lab Stem Cells/iPSCs
amfAR News—In an interview with the Foundation for AIDS Research, Melanie Ott, director of the Gladstone Institute of Virology, discusses the future of HIV research, and describes how lessons from the field have laid a strong foundation for fighting other viral diseases.
Gladstone Experts HIV/AIDS Virology Ott Lab
The San Francisco Experience—In a podcast interview, Gladstone President Deepak Srivastava discusses the mission of Gladstone Institutes, and describes how advances in stem cell biology, genome engineering, and artificial intelligence are making it possible to understand the core of diseases and develop new cures.
Gladstone Experts Srivastava Lab AI CRISPR/Gene Editing Stem Cells/iPSCs
